Works matching IS 2160763X AND DT 2019 AND VI 8 AND IP 5

Results: 16

Erratum.

Published in:: 2019
Publication type:: Correction Notice

Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community‐Acquired Pneumonia Treated With Ceftaroline Fosamil.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 682, doi. 10.1002/cpdd.673

By:

Li, Jianguo;
Das, Shampa;
Zhou, Diansong;
Al‐Huniti, Nidal

Publication type:

Article

A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control Participants.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 674, doi. 10.1002/cpdd.664

By:

Parasrampuria, Ridhi;
Ford, Susan L.;
Lou, Yu;
Fu, Caifeng;
Bakshi, Kalpana K.;
Tenorio, Allan R.;
Trezza, Christine;
Spreen, William R.;
Patel, Parul

Publication type:

Article

Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 647, doi. 10.1002/cpdd.663

By:

Shen, Zancong;
Lee, Caroline A.;
Valdez, Shakti;
Yang, Xiaojuan;
Wilson, David M.;
Flanagan, Talia;
Gillen, Michael

Publication type:

Article

Lesinurad: Evaluation of Pharmacokinetic and Pharmacodynamic Interactions With Warfarin in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 657, doi. 10.1002/cpdd.662

By:

Shen, Zancong;
Lee, Caroline A.;
Wallach, Kathleen;
Valdez, Shakti;
Wilson, David M.;
Kerr, Bradley;
Gillen, Michael

Publication type:

Article

The Relative Bioavailability and Effects of Food and Acid‐Reducing Agents on Filgotinib Tablets in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 585, doi. 10.1002/cpdd.659

By:

Anderson, Kacey;
Zheng, Hao;
Kotecha, Mona;
Cuvin, Jennifer;
Scott, Bob;
Sharma, Shringi;
Qin, Ann Ran‐Ran;
Namour, Florence;
Xin, Yan

Publication type:

Article

A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Patients With Hepatic Impairment and Healthy Matched Controls.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 664, doi. 10.1002/cpdd.655

By:

Shaik, Jafar Sadik B.;
Ford, Susan L.;
Lou, Yu;
Zhang, Zhiping;
Bakshi, Kalpana K.;
Tenorio, Allan R.;
Trezza, Christine;
Spreen, William R.;
Patel, Parul

Publication type:

Article

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 612, doi. 10.1002/cpdd.631

By:

Ino, Hiroko;
Doi, Yohei;
Liefaard, Lia;
Cookson, Louise;
Chen, Chao;
Itoh, Hiroshi;
Igarashi, Harue;
Nakano, Atsushi

Publication type:

Article

An Open‐Label, Single‐Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 595, doi. 10.1002/cpdd.630

By:

Kato, Kota;
den Adel, Martin;
Groenendaal‐van de Meent, Dorien;
Ohtsu, Yoshiaki;
Takada, Akitsugu;
Katashima, Masataka

Publication type:

Article

Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed‐Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 619, doi. 10.1002/cpdd.629

By:

Sahasrabudhe, Vaishali;
Fediuk, Daryl J.;
Matschke, Kyle;
Shi, Haihong;
Liang, Yali;
Hickman, Anne;
Bass, Almasa;
Terra, Steven G.;
Zhou, Susan;
Krishna, Rajesh;
Dawra, Vikas K.

Publication type:

Article

A Randomized, Placebo‐Controlled, Multiple‐Ascending‐Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 564, doi. 10.1002/cpdd.627

By:

Hanrahan, John P.;
Wakefield, James D.;
Wilson, Phebe J.;
Mihova, Marina;
Chickering, Jennifer G.;
Ruff, Dennis;
Hall, Michael;
Milne, G. Todd;
Currie, Mark G.;
Profy, Albert T.

Publication type:

Article

Pharmacokinetics of a Lobeglitazone/Metformin Fixed‐Dose Combination Tablet (CKD‐395 0.5/1000 mg) Versus Concomitant Administration of Single Agents and the Effect of Food on the Metabolism of CKD‐395 in Healthy Male Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 576, doi. 10.1002/cpdd.625

By:

Kim, Sun‐Young;
Jeon, Ji‐Young;
Park, Shin Jung;
Kim, Min‐Gul

Publication type:

Article

A Phase 1 Assessment of the QT Interval in Healthy Adults Following Exposure to Rolapitant, a Cancer Supportive Care Antiemetic.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 603, doi. 10.1002/cpdd.619

By:

Wang, Xiaodong;
Zhang, Zhi‐Yi;
Wang, Jing;
Kansra, Vikram

Publication type:

Article

Pharmacokinetics and Safety of CSL112 (Apolipoprotein A‐I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 628, doi. 10.1002/cpdd.618

By:

Tortorici, Michael A.;
Duffy, Danielle;
Evans, Rebecca;
Feaster, John;
Gille, Andreas;
Mant, Timothy G. K.;
Wright, Samuel D.;
D'Andrea, Denise

Publication type:

Article

Characterizing the Sources of Pharmacokinetic Variability for TAK‐117 (Serabelisib), an Investigational Phosphoinositide 3‐Kinase Alpha Inhibitor: A Clinical Biopharmaceutics Study to Inform Development Strategy.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 637, doi. 10.1002/cpdd.613

By:

Patel, Chirag G.;
Rangachari, Lakshmi;
Patti, Mark;
Griffin, Celina;
Shou, Yaping;
Venkatakrishnan, Karthik

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 559, doi. 10.1002/cpdd.593
Publication type:: Article